Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.

TitleEvaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Publication TypeJournal Article
Year of Publication1997
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine
Volume38
Issue11
Pagination1762-7
ISSN0161-5505
Abstract

Boron neutron capture therapy (BNCT) using 4-[10B]boronophenylalanine-fructose (BPA-Fr) is in Phase II clinical trials to validate BNCT as a treatment for glioblastoma multiforme and melanoma. Successful BNCT depends on knowledge of the distribution of boron-containing agents in both tumor and normal tissue as currently determined by chemical confirmation of boron deposition in surgically removed malignant tissue before BNCT.

URLhttp://jnm.snmjournals.org/cgi/pmidlookup?view=long&pmid=9374349
Short TitleJ Nucl Med
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading